Genetic variation in the beta2-adrenergic receptor but not catecholamine- O -methyltransferase predisposes to chronic pain: Results from the 1958 British Birth Cohort Study
Authors:
- Lynne J. HockingLHLynne J. Hocking
- Blair H. SmithBSBlair H. Smith
- Gareth T. JonesGJGareth T. Jones
- David M. ReidDRDavid M. Reid
- David P. StrachanDSDavid P. Strachan
- Gary J. MacfarlaneGMGary J. Macfarlane
- 1 April 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 149 (1) , 143-151
Abstract
More than 1 in 10 adults in the general population experience chronic widespread body pain (CWP), which lies at one end of a continuous spectrum of pain ranging in both severity and duration. Neuroendocrine factors can modify the effect of known psychological and psychosocial risk factors for progression along the spectrum of pain and development of CWP, and genetic variants that affect neuroendocrine and neural processing potentially affect susceptibility to chronic pain development. We have examined variants across genes encoding the beta2-adrenergic receptor (ADRB2) and catecholamine-O-methyltransferase (COMT) - key neuroendocrine signalling factors - in a large population-based sample to determine whether these may be involved in pain progression and CWP development. A nested association study was conducted using individuals from the 1958 British Birth Cohort Study who had been assessed for pain status. Genotypes were available for nine single nucleotide polymorphisms (SNPs) across ADRB2 and 11 SNPs across COMT. ADRB2 SNPs rs12654778 and rs1042713 were associated either with CWP alone (p=0.02 for both) or with position along pain spectrum (pain status; p=0.04). Common functional ADRB2 haplotype combinations were also associated with pain status (p(model)=0.002) and, further, with both extent and duration of pain (p(model)=0.003 and p(model)=0.002, respectively). There were no associations of either CWP or pain status with COMT genotypes or haplotypes. These results are the first to suggest that functional ADRB2 variants are involved in regulating pain status at a population level. A role for COMT in chronic pain development was not identified, though could not be excluded.Keywords
This publication has 44 references indexed in Scilit:
- Diverse Evolutionary Histories for β-adrenoreceptor Genes in HumansThe American Journal of Human Genetics, 2009
- Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgiaArthritis Research & Therapy, 2007
- A genome-wide association study of global gene expressionNature Genetics, 2007
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- A tutorial on statistical methods for population association studiesNature Reviews Genetics, 2006
- Managing low back pain presenting to primary care: Where do we go from here?Pain, 2006
- Three major haplotypes of the β2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorderAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- The prevalence and characteristics of fibromyalgia in the general populationArthritis & Rheumatism, 1995